Literature DB >> 20573402

The combination of gene perturbation assay and ChIP-chip reveals functional direct target genes for IRF8 in THP-1 cells.

Atsutaka Kubosaki1, Gabriella Lindgren, Michihira Tagami, Christophe Simon, Yasuhiro Tomaru, Hisashi Miura, Takahiro Suzuki, Erik Arner, Alistair R R Forrest, Katharine M Irvine, Kate Schroder, Yuki Hasegawa, Mutsumi Kanamori-Katayama, Michael Rehli, David A Hume, Jun Kawai, Masanori Suzuki, Harukazu Suzuki, Yoshihide Hayashizaki.   

Abstract

Gene regulatory networks in living cells are controlled by the interaction of multiple cell type-specific transcription regulators with DNA binding sites in target genes. Interferon regulatory factor 8 (IRF8), also known as interferon consensus sequence binding protein (ICSBP), is a transcription factor expressed predominantly in myeloid and lymphoid cell lineages. To find the functional direct target genes of IRF8, the gene expression profiles of siRNA knockdown samples and genome-wide binding locations by ChIP-chip were analyzed in THP-1 myelomonocytic leukemia cells. Consequently, 84 genes were identified as functional direct targets. The ETS family transcription factor PU.1, also known as SPI1, binds to IRF8 and regulates basal transcription in macrophages. Using the same approach, we identified 53 direct target genes of PU.1; these overlapped with 19 IRF8 targets. These 19 genes included key molecules of IFN signaling such as OAS1 and IRF9, but excluded other IFN-related genes amongst the IRF8 functional direct target genes. We suggest that IRF8 and PU.1 can have both combined, and independent actions on different promoters in myeloid cells. (c) 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20573402     DOI: 10.1016/j.molimm.2010.05.289

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  20 in total

1.  The Folate Cycle Enzyme MTHFR Is a Critical Regulator of Cell Response to MYC-Targeting Therapies.

Authors:  Angela Su; Frank Ling; Camille Lobry; Kris C Wood; Raphael Itzykson; Alexandre Puissant; Camille Vaganay; Gaetano Sodaro; Chaïma Benaksas; Reinaldo Dal Bello; Antoine Forget; Bryann Pardieu; Kevin H Lin; Justine C Rutter; Christopher F Bassil; Gael Fortin; Justine Pasanisi; Iléana Antony-Debré; Gabriela Alexe; Jean-François Benoist; Alain Pruvost; Yana Pikman; Jun Qi; Marie-Hélène Schlageter; Jean-Baptiste Micol; Giovanni Roti; Thomas Cluzeau; Hervé Dombret; Claude Preudhomme; Nina Fenouille; Lina Benajiba; Hava M Golan; Kimberly Stegmaier
Journal:  Cancer Discov       Date:  2020-08-21       Impact factor: 39.397

2.  Resection of non-small cell lung cancers reverses tumor-induced gene expression changes in the peripheral immune system.

Authors:  Andrew V Kossenkov; Anil Vachani; Celia Chang; Calen Nichols; Shere Billouin; Wenhwai Horng; William N Rom; Steven M Albelda; Michael K Showe; Louise C Showe
Journal:  Clin Cancer Res       Date:  2011-08-01       Impact factor: 12.531

Review 3.  Genomic and biochemical insights into the specificity of ETS transcription factors.

Authors:  Peter C Hollenhorst; Lawrence P McIntosh; Barbara J Graves
Journal:  Annu Rev Biochem       Date:  2011       Impact factor: 23.643

4.  Bile acid analogues are activators of pyrin inflammasome.

Authors:  Irina Alimov; Suchithra Menon; Nadire Cochran; Rob Maher; Qiong Wang; John Alford; John B Concannon; Zinger Yang; Edmund Harrington; Luis Llamas; Alicia Lindeman; Gregory Hoffman; Tim Schuhmann; Carsten Russ; John Reece-Hoyes; Stephen M Canham; Xinming Cai
Journal:  J Biol Chem       Date:  2019-01-15       Impact factor: 5.157

5.  Essential role of the IRF8-KLF4 transcription factor cascade in murine monocyte differentiation.

Authors:  Daisuke Kurotaki; Naoki Osato; Akira Nishiyama; Michio Yamamoto; Tatsuma Ban; Hideaki Sato; Jun Nakabayashi; Marina Umehara; Noriko Miyake; Naomichi Matsumoto; Masatoshi Nakazawa; Keiko Ozato; Tomohiko Tamura
Journal:  Blood       Date:  2013-01-14       Impact factor: 22.113

6.  Type I Interferon Receptor Variants in Gene Regulatory Regions are Associated with Susceptibility to Cerebral Malaria in Malawi.

Authors:  Catherine Manix Feintuch; Archana Tare; Lucas R Cusumano; Jacqueline Benayoun; Seungjin Ryu; Alick Sixpence; Karl Seydel; Miriam Laufer; Terrie Taylor; Yousin Suh; Johanna P Daily
Journal:  Am J Trop Med Hyg       Date:  2018-04-05       Impact factor: 2.345

7.  IRF8 mutations and human dendritic-cell immunodeficiency.

Authors:  Sophie Hambleton; Sandra Salem; Jacinta Bustamante; Venetia Bigley; Stéphanie Boisson-Dupuis; Joana Azevedo; Anny Fortin; Muzlifah Haniffa; Lourdes Ceron-Gutierrez; Chris M Bacon; Geetha Menon; Céline Trouillet; David McDonald; Peter Carey; Florent Ginhoux; Laia Alsina; Timothy J Zumwalt; Xiao-Fei Kong; Dinakantha Kumararatne; Karina Butler; Marjorie Hubeau; Jacqueline Feinberg; Saleh Al-Muhsen; Andrew Cant; Laurent Abel; Damien Chaussabel; Rainer Doffinger; Eduardo Talesnik; Anete Grumach; Alberto Duarte; Katia Abarca; Dewton Moraes-Vasconcelos; David Burk; Albert Berghuis; Frédéric Geissmann; Matthew Collin; Jean-Laurent Casanova; Philippe Gros
Journal:  N Engl J Med       Date:  2011-04-27       Impact factor: 91.245

8.  DNA methylation protects against cisplatin-induced kidney injury by regulating specific genes, including interferon regulatory factor 8.

Authors:  Chunyuan Guo; Lirong Pei; Xiao Xiao; Qingqing Wei; Jian-Kang Chen; Han-Fei Ding; Shuang Huang; Guoping Fan; Huidong Shi; Zheng Dong
Journal:  Kidney Int       Date:  2017-07-12       Impact factor: 10.612

9.  IFN regulatory factor 8 is a key constitutive determinant of the morphological and molecular properties of microglia in the CNS.

Authors:  Carsten Minten; Rachael Terry; Celine Deffrasnes; Nicholas J C King; Iain L Campbell
Journal:  PLoS One       Date:  2012-11-14       Impact factor: 3.240

10.  CDK8 kinase phosphorylates transcription factor STAT1 to selectively regulate the interferon response.

Authors:  Joanna Bancerek; Zachary C Poss; Iris Steinparzer; Vitaly Sedlyarov; Thaddäus Pfaffenwimmer; Ivana Mikulic; Lars Dölken; Birgit Strobl; Mathias Müller; Dylan J Taatjes; Pavel Kovarik
Journal:  Immunity       Date:  2013-01-24       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.